Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.1200
+0.0001 (0.08%)
At close: Oct 24, 2025
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $4.04 million as of October 27, 2025. Its market cap has increased by 46.25% in one year.
Market Cap
4.04M
Enterprise Value
11.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 4.04M, a decrease of -99.90%. That is a compound annual growth rate of -22.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 4.04M | 4.58% |
| Dec 31, 2024 | 3.86M | 4.27% |
| Dec 29, 2023 | 3.70M | -43.61% |
| Dec 30, 2022 | 6.56M | -85.53% |
| Dec 31, 2021 | 45.36M | -47.74% |
| Dec 31, 2020 | 86.80M | -50.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 649.45M |
| Glass House Brands | 618.32M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| American Oncology Network | 297.14M |